S&P 500   4,625.27 (-0.64%)
DOW   34,897.55 (-0.68%)
QQQ   398.67 (-0.26%)
AAPL   159.72 (-0.32%)
MSFT   336.21 (-0.12%)
FB   336.47 (-0.46%)
GOOGL   2,902.38 (-0.28%)
AMZN   3,575.05 (+0.38%)
TSLA   1,141.45 (+0.39%)
NVDA   333.94 (+0.05%)
BABA   130.30 (-1.00%)
NIO   40.31 (-0.37%)
CGC   10.88 (-1.63%)
AMD   163.73 (+1.12%)
GE   97.13 (-1.29%)
MU   85.90 (-0.28%)
T   23.68 (-0.88%)
F   19.50 (-0.86%)
DIS   146.55 (-0.85%)
ACB   6.38 (-0.93%)
AMC   36.65 (-0.52%)
PFE   52.70 (+0.57%)
BA   196.22 (-1.15%)
S&P 500   4,625.27 (-0.64%)
DOW   34,897.55 (-0.68%)
QQQ   398.67 (-0.26%)
AAPL   159.72 (-0.32%)
MSFT   336.21 (-0.12%)
FB   336.47 (-0.46%)
GOOGL   2,902.38 (-0.28%)
AMZN   3,575.05 (+0.38%)
TSLA   1,141.45 (+0.39%)
NVDA   333.94 (+0.05%)
BABA   130.30 (-1.00%)
NIO   40.31 (-0.37%)
CGC   10.88 (-1.63%)
AMD   163.73 (+1.12%)
GE   97.13 (-1.29%)
MU   85.90 (-0.28%)
T   23.68 (-0.88%)
F   19.50 (-0.86%)
DIS   146.55 (-0.85%)
ACB   6.38 (-0.93%)
AMC   36.65 (-0.52%)
PFE   52.70 (+0.57%)
BA   196.22 (-1.15%)
S&P 500   4,625.27 (-0.64%)
DOW   34,897.55 (-0.68%)
QQQ   398.67 (-0.26%)
AAPL   159.72 (-0.32%)
MSFT   336.21 (-0.12%)
FB   336.47 (-0.46%)
GOOGL   2,902.38 (-0.28%)
AMZN   3,575.05 (+0.38%)
TSLA   1,141.45 (+0.39%)
NVDA   333.94 (+0.05%)
BABA   130.30 (-1.00%)
NIO   40.31 (-0.37%)
CGC   10.88 (-1.63%)
AMD   163.73 (+1.12%)
GE   97.13 (-1.29%)
MU   85.90 (-0.28%)
T   23.68 (-0.88%)
F   19.50 (-0.86%)
DIS   146.55 (-0.85%)
ACB   6.38 (-0.93%)
AMC   36.65 (-0.52%)
PFE   52.70 (+0.57%)
BA   196.22 (-1.15%)
S&P 500   4,625.27 (-0.64%)
DOW   34,897.55 (-0.68%)
QQQ   398.67 (-0.26%)
AAPL   159.72 (-0.32%)
MSFT   336.21 (-0.12%)
FB   336.47 (-0.46%)
GOOGL   2,902.38 (-0.28%)
AMZN   3,575.05 (+0.38%)
TSLA   1,141.45 (+0.39%)
NVDA   333.94 (+0.05%)
BABA   130.30 (-1.00%)
NIO   40.31 (-0.37%)
CGC   10.88 (-1.63%)
AMD   163.73 (+1.12%)
GE   97.13 (-1.29%)
MU   85.90 (-0.28%)
T   23.68 (-0.88%)
F   19.50 (-0.86%)
DIS   146.55 (-0.85%)
ACB   6.38 (-0.93%)
AMC   36.65 (-0.52%)
PFE   52.70 (+0.57%)
BA   196.22 (-1.15%)
OTC:BBLG

Bone Biologics Stock Forecast, Price & News

$4.11
+0.06 (+1.48%)
(As of 11/29/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.00
$4.19
50-Day Range
N/A
52-Week Range
$3.32
$7.12
Volume
130,232 shs
Average Volume
1.35 million shs
Market Capitalization
$42.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BBLG News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.


About Bone Biologics

Bone Biologics Corp. is a developer of orthobiologic products for spine fusion markets. Bone Biologics Corp. is based in BURLINGTON, Mass.

Headlines

Bone Biologics Corp's Quiet Period To End on November 22nd (OTC:BBLG)
November 15, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$42.33 million
Optionable
Not Optionable

Company Calendar

Today
11/30/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Bone Biologics (OTC:BBLG) Frequently Asked Questions

What is Bone Biologics' stock symbol?

Bone Biologics trades on the OTC under the ticker symbol "BBLG."

When did Bone Biologics' quiet period expire?

Bone Biologics' quiet period expired on Monday, November 22nd. Bone Biologics had issued 1,510,455 shares in its public offering on October 13th. The total size of the offering was $7,929,889 based on an initial share price of $5.25. During Bone Biologics' quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Bone Biologics?

Shares of BBLG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bone Biologics' stock price today?

One share of BBLG stock can currently be purchased for approximately $4.11.

How much money does Bone Biologics make?

Bone Biologics has a market capitalization of $42.33 million.

How many employees does Bone Biologics have?

Bone Biologics employs 2 workers across the globe.

What is Bone Biologics' official website?

The official website for Bone Biologics is www.bonebiologics.com.

How can I contact Bone Biologics?

The company can be reached via phone at 781-552-4452.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.